UBS Group’s LivaNova LIVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.5M | Sell |
370,069
-177,485
| -32% | -$11.4M | ﹤0.01% | 2407 |
|
|
2025
Q4 | $33.7M | Buy |
547,554
+252,766
| +86% | +$14.4M | 0.01% | 2046 |
|
|
2025
Q3 | $15.4M | Sell |
294,788
-21,085
| -7% | -$1.06M | ﹤0.01% | 2853 |
|
|
2025
Q2 | $14.2M | Sell |
315,873
-429,527
| -58% | -$17.7M | ﹤0.01% | 2731 |
|
|
2025
Q1 | $29.3M | Sell |
745,400
-51,969
| -7% | -$2.33M | 0.01% | 1981 |
|
|
2024
Q4 | $36.9M | Buy |
797,369
+756,010
| +1,828% | +$38.8M | 0.01% | 1734 |
|
|
2024
Q3 | $2.17M | Buy |
41,359
+19,261
| +87% | +$955K | ﹤0.01% | 3903 |
|
|
2024
Q2 | $1.21M | Sell |
22,098
-39,322
| -64% | -$2.24M | ﹤0.01% | 4232 |
|
|
2024
Q1 | $3.44M | Sell |
61,420
-21,294
| -26% | -$1.11M | ﹤0.01% | 3375 |
|
|
2023
Q4 | $4.28M | Buy |
82,714
+20,754
| +33% | +$1M | ﹤0.01% | 2949 |
|
|
2023
Q3 | $3.28M | Sell |
61,960
-2,731
| -4% | -$150K | ﹤0.01% | 2972 |
|
|
2023
Q2 | $3.33M | Sell |
64,691
-1,977
| -3% | -$92.8K | ﹤0.01% | 2999 |
|
|
2023
Q1 | $2.91M | Buy |
66,668
+23,165
| +53% | +$1.17M | ﹤0.01% | 3029 |
|
|
2022
Q4 | $2.42M | Buy |
43,503
+3,777
| +10% | +$193K | ﹤0.01% | 3208 |
|
|
2022
Q3 | $2.02M | Sell |
39,726
-4,849
| -11% | -$288K | ﹤0.01% | 3155 |
|
|
2022
Q2 | $2.79M | Buy |
44,575
+14,153
| +47% | +$1M | ﹤0.01% | 2860 |
|
|
2022
Q1 | $2.49M | Sell |
30,422
-23,026
| -43% | -$1.79M | ﹤0.01% | 3225 |
|
|
2021
Q4 | $4.67M | Buy |
53,448
+30,796
| +136% | +$2.57M | ﹤0.01% | 2894 |
|
|
2021
Q3 | $1.79M | Buy |
22,652
+1,678
| +8% | +$138K | ﹤0.01% | 3661 |
|
|
2021
Q2 | $1.76M | Sell |
20,974
-5,340
| -20% | -$440K | ﹤0.01% | 3693 |
|
|
2021
Q1 | $1.94M | Sell |
26,314
-1,730
| -6% | -$123K | ﹤0.01% | 3592 |
|
|
2020
Q4 | $1.86M | Buy |
28,044
+12,395
| +79% | +$689K | ﹤0.01% | 3467 |
|
|
2020
Q3 | $707K | Sell |
15,649
-3,767
| -19% | -$182K | ﹤0.01% | 3896 |
|
|
2020
Q2 | $935K | Sell |
19,416
-48,740
| -72% | -$2.44M | ﹤0.01% | 3565 |
|
|
2020
Q1 | $3.08M | Sell |
68,156
-92,071
| -57% | -$5.96M | ﹤0.01% | 2357 |
|
|
2019
Q4 | $12.1M | Buy |
160,227
+53,488
| +50% | +$4.06M | ﹤0.01% | 1782 |
|
|
2019
Q3 | $7.88M | Buy |
106,739
+29,613
| +38% | +$2.28M | ﹤0.01% | 1958 |
|
|
2019
Q2 | $5.55M | Buy |
77,126
+29,176
| +61% | +$2.14M | ﹤0.01% | 2233 |
|
|
2019
Q1 | $4.66M | Sell |
47,950
-28,398
| -37% | -$2.65M | ﹤0.01% | 2264 |
|
|
2018
Q4 | $6.98M | Buy |
76,348
+8,371
| +12% | +$899K | ﹤0.01% | 1874 |
|
|
2018
Q3 | $8.43M | Buy |
67,977
+14,227
| +26% | +$1.68M | ﹤0.01% | 1918 |
|
|
2018
Q2 | $5.37M | Buy |
53,750
+39,273
| +271% | +$3.57M | ﹤0.01% | 2282 |
|
|
2018
Q1 | $1.28M | Buy |
14,477
+4,683
| +48% | +$399K | ﹤0.01% | 3523 |
|
|
2017
Q4 | $783K | Sell |
9,794
-1,501
| -13% | -$119K | ﹤0.01% | 3971 |
|
|
2017
Q3 | $792K | Buy |
11,295
+4,602
| +69% | +$292K | ﹤0.01% | 3884 |
|
|
2017
Q2 | $409K | Sell |
6,693
-3,797
| -36% | -$215K | ﹤0.01% | 4253 |
|
|
2017
Q1 | $514K | Sell |
10,490
-17,742
| -63% | -$863K | ﹤0.01% | 4012 |
|
|
2016
Q4 | $1.27M | Buy |
28,232
+17,451
| +162% | +$857K | ﹤0.01% | 3355 |
|
|
2016
Q3 | $648K | Sell |
10,781
-3,128
| -22% | -$180K | ﹤0.01% | 3734 |
|
|
2016
Q2 | $698K | Buy |
13,909
+3,389
| +32% | +$171K | ﹤0.01% | 3654 |
|
|
2016
Q1 | $567K | Buy |
10,520
+1,418
| +16% | +$78.8K | ﹤0.01% | 3683 |
|
|
2015
Q4 | $541K | Buy |
+9,102
| New | +$552K | ﹤0.01% | 3880 |
|
Other funds holding LIVN
UBS Group's LIVN Position: Q1 2026 in Review
UBS Group reduced its LivaNova (LIVN) stake by 32% in Q1 2026, selling an estimated $11.4M and leaving 370,069 shares worth $23.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2407.
UBS Group first reported a position in LIVN in Q4 2015 and has held it in 42 quarters since. The position peaked at $36.9M in Q4 2024. 290 funds tracked by Wall St. Rank hold LIVN as of Q1 2026.
- UBS Group held 370,069 shares of LivaNova worth $23.5M as of Q1 2026.
- UBS Group sold 177,485 LivaNova shares in Q1 2026, an estimated $11.4M.
- LivaNova made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2407 holding.
- UBS Group first reported a position in LivaNova in Q4 2015 and has held it in 42 quarters since.
- UBS Group's LivaNova position peaked at $36.9M in Q4 2024.
- 290 funds tracked by Wall St. Rank held LivaNova as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.